| aVR sign as a risk factor for life-threatening arrhythmic events in patients with Brugada syndrome MAB Bigi, A Aslani, S Shahrzad Heart Rhythm 4 (8), 1009-1012, 2007 | 155 | 2007 |
| The future of drug discovery and development: shifting emphasis towards personalized medicine A Amir-Aslani, V Mangematin Technological Forecasting and Social Change 77 (2), 203-217, 2010 | 103 | 2010 |
| Aortic root size and prevalence of aortic regurgitation in elite strength trained athletes MAB Bigi, A Aslani The American journal of cardiology 100 (3), 528-530, 2007 | 94 | 2007 |
| Comparison of the effect of omega-3 supplements and fresh fish on lipid profile: a randomized, open-labeled trial MJ Zibaeenezhad, M Ghavipisheh, A Attar, A Aslani Nutrition & diabetes 7 (12), 1, 2017 | 91 | 2017 |
| Is technology integration the solution to biotechnology's low research and development productivity? A Amir-Aslani, S Negassi Technovation 26 (5-6), 573-582, 2006 | 66 | 2006 |
| Clinical predictors of atrial fibrillation in Brugada syndrome MA Babai Bigi, A Aslani, S Shahrzad Europace 9 (10), 947-950, 2007 | 64 | 2007 |
| Left atrial volume: a novel predictor of hepatopulmonary syndrome M Zamirian, A Aslani, S Shahrzad Official journal of the American College of Gastroenterology| ACG 102 (7 …, 2007 | 61 | 2007 |
| Short QT interval: a novel predictor of androgen abuse in strength trained athletes MAB Bigi, A Aslani, A Aslani Annals of noninvasive electrocardiology 14 (1), 35-39, 2009 | 58 | 2009 |
| Effect of endurance and strength exercise on release of brain natriuretic peptide S Bordbar, E Rahimi, N Ahmadi, MAB Bigi, A Aslani Journal of cardiovascular disease research 3 (1), 22-25, 2012 | 43 | 2012 |
| Prevalence of Brugada sign in patients presenting with palpitation in southern Iran MA Babaee Bigi, A Aslani, S Shahrzad Europace 9 (4), 252-255, 2007 | 38 | 2007 |
| Significance of cardiac autonomic neuropathy in risk stratification of Brugada syndrome MA Babaee Bigi, A Aslani, A Aslani Europace 10 (7), 821-824, 2008 | 34 | 2008 |
| The effect of left ventricular (LV) remodeling on ventricular arrhythmia in cardiac resynchronization therapy (CRT‐D) patients (antiarrhythmic effect of CRT) S Shahrzad, NK Soleiman, S Taban, A Alizadeh, A Aslani, A Tavoosi, ... Pacing and clinical electrophysiology 35 (5), 592-597, 2012 | 30 | 2012 |
| Effect of chronic cocaine abuse on the elastic properties of aorta MAB Bigi, A Aslani, M Mehrpour Echocardiography 25 (3), 308-311, 2008 | 30 | 2008 |
| Significance of aortic atheroma in elderly patients with ischemic stroke: A hospital-based study and literature review MB Sharifkazemi, A Aslani, M Zamirian, AR Moaref Clinical neurology and neurosurgery 109 (4), 311-316, 2007 | 30 | 2007 |
| Cardiac findings in Weill-Marchesani syndrome J Kojuri, MR Razeghinejad, A Aslani American journal of medical genetics. Part A 143 (17), 2062, 2007 | 29 | 2007 |
| Comparative structural analysis by [1H, 31P]-NMR and restrained molecular dynamics of two DNA hairpins from a strong DNA topoisomerase II cleavage site O Mauffret, A Amir-Aslani, RG Maroun, M Monnot, E Lescot, ... Journal of molecular biology 283 (3), 643-655, 1998 | 29 | 1998 |
| Prediction of intrapulmonary right to left shunt with left atrial size in patients with liver cirrhosis M Zamirian, A Aslani, MB Sharifkazemi European Journal of Echocardiography 9 (1), 1-4, 2008 | 24 | 2008 |
| The rise of the professional master's degree: the answer to the postdoc/PhD bubble M Theodosiou, JP Rennard, A Amir-Aslani Nature Biotechnology 30 (4), 367-368, 2012 | 23 | 2012 |
| The hairpin structure of a topoisomerase II site DNA strand analyzed by combined NMR and energy minimization methods A Amir-Aslani, O Mauffret, F Sourgen, S Neplaz, RG Maroun, E Lescot, ... Journal of molecular biology 263 (5), 776-788, 1996 | 23 | 1996 |
| Hairpins in a DNA site for topoisomerase II studied by 1 H-and 31 P-NMR A Amir-Aslani, O Mauffret, P Bittoun, F Sourgen, M Monnot, E Lescot, ... Nucleic acids research 23 (19), 3850-3857, 1995 | 23 | 1995 |
